|
New Federal Guidelines For Physician–Pharmaceutical Industry Relations: The Politics Of Policy Formation
Susan Chimonas and
David J. Rothman
In October 2002 the federal government issued a draft "Compliance Program Guidance for Pharmaceutical Manufacturers." The draft Guidance questioned the legality of many arrangements heretofore left to the discretion of physicians and drug companies, including industry-funded educational and research grants, consultantcies, and gifts. Medical organizations and drug manufacturers proposed major revisions to the draft, arguing that current practices were in everyone’s best interest. To evaluate the impact of their responses, we compare the draft, the changes requested by industry and organized medicine, and the final Guidance document (issued in April 2003). We also explore the implications—some intended, others unanticipated—of the final document.
       What's this?
This article has been cited by other articles:
|
|
|
|
 
D. J. Rothman, W. J. McDonald, C. D. Berkowitz, S. C. Chimonas, C. D. DeAngelis, R. W. Hale, S. E. Nissen, J. E. Osborn, J. H. Scully Jr, G. E. Thomson, et al.
Professional Medical Associations and Their Relationships With Industry: A Proposal for Controlling Conflict of Interest
JAMA,
April 1, 2009;
301(13):
1367 - 1372.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Rothman
Academic Medical Centers and Financial Conflicts of Interest
JAMA,
February 13, 2008;
299(6):
695 - 697.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. V. Iserson, R. J. Cerfolio, and R. M. Sade
Politely Refuse the Pen and Note Pad: Gifts From Industry to Physicians Harm Patients
Ann. Thorac. Surg.,
October 1, 2007;
84(4):
1077 - 1084.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. L Pinto, E. Lipowski, R. Segal, C. Kimberlin, and J. Algina
Physicians' intent to comply with the American Medical Association's guidelines on gifts from the pharmaceutical industry
J. Med. Ethics,
June 1, 2007;
33(6):
313 - 319.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Steinman, L. A. Bero, M.-M. Chren, and C. S. Landefeld
Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents
Ann Intern Med,
August 15, 2006;
145(4):
284 - 293.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Henney
Safeguarding Patient Welfare: Who's In Charge?
Ann Intern Med,
August 15, 2006;
145(4):
305 - 307.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Olcott IV
The Pacific Coast Surgical Association in the New Millennium
Arch Surg,
August 1, 2006;
141(8):
729 - 733.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E. Nissen and President, American College of Cardiology
President's Page: American College of Cardiology Fellowship: Where Ideals and Personal Responsibility Intersect
J. Am. Coll. Cardiol.,
May 2, 2006;
47(9):
1901 - 1903.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. A. Brennan, D. J. Rothman, L. Blank, D. Blumenthal, S. C. Chimonas, J. J. Cohen, J. Goldman, J. P. Kassirer, H. Kimball, J. Naughton, et al.
Health Industry Practices That Create Conflicts of Interest: A Policy Proposal for Academic Medical Centers
JAMA,
January 25, 2006;
295(4):
429 - 433.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
